title: [Platelet activation and platelet aggregation in the arteriosclerotic endothelium: pathophysiological aspects and new therapeutic concepts].
authors.affiliation: Medizinische Klinik II und Poliklinik, Universität Erlangen-Nürnberg.
authors.forename: G
authors.initials: G
authors.lastname: Pongratz
authors.forename: K
authors.initials: K
authors.lastname: Pohle
authors.forename: D
authors.initials: D
authors.lastname: Stingl
authors.forename: K
authors.initials: K
authors.lastname: Bachmann
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology; D001161:Arteriosclerosis / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors; D017482:Receptors, Thromboxane / Q000037:antagonists & inhibitors; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000517:prevention & control / Q000628:therapy*; D013988:Ticlopidine / Q000494:pharmacology
chemical_list: D000925:Anticoagulants; D016861:Cyclooxygenase Inhibitors; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013917:Thrombin; D013988:Ticlopidine
vernacular_title: Thrombozytenaktivierung und Thrombozytenaggregation am arteriosklerotisch veränderten Endothel. Pathophysiologische Aspekte und neue therapeutische Konzepte.